Matregenix announced a winner of the 2022 Medical Innovation Challenge at Defense TechConnect Innovation Summit

Advanced Technology International (ATI), TechConnect and four MedTech industry consortia today announced Matregenix as a winner of the 2022 Medical Innovation Challenge at the Defense TechConnect Innovation Summit. The award comes with $25k cash prize and access to consortia that represent $20B in defense contracting authority. This award is sponsored by ATI | Advanced Technology International, Medical Technology Enterprise Consortium, Countering Weapons of Mass Destruction Consortium, and SHIC | Senior Healthcare Innovation Consortium in honor of innovation with the potential to help solve our nation’s most critical medical and health tech challenges.

Held Sept. 27-29, 2022, at Gaylord National Hotel & Convention Center in National Harbor, Md., Defense TechConnect is the nation’s largest annual gathering of non-traditional, dual-use emerging technologies aligned with government priority requirements. Dr. Sherif Soliman, the CEO of Matregenix pitched the company’s new developed platform technology for soft-tissue repair applications.

Matregenix Announces Phase 1 SBIR Grant Award from National Institutes of Health
Matregenix Unveils New HEPA Filter Media with Significant Reduction in Pressure Drop, Saving Energy and Improving Air Quality